Neuland Laboratories Limited (BOM:524558)
India · Delayed Price · Currency is INR 13,612
+444 (3.37%)
At close: Jan 22, 2026
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 174.64 billion as of January 23, 2026. Its market cap has decreased by -1.28% in one year.
Market Cap
174.64B
Enterprise Value
175.60B
Revenue
15.33B
Ranking
n/a
PE Ratio
72.72
Stock Price
13,611.80
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 174.64B, an increase of 52,009.00%. That is a compound annual growth rate of 28.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 174.64B | -10.39% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sudeep Pharma | 60.82B |
| Shilpa Medicare | 54.48B |
| Gujarat Themis Biosyn | 36.48B |
| Suven Life Sciences | 30.77B |
| IOL Chemicals and Pharmaceuticals | 21.01B |
| Bajaj HealthCare | 11.56B |
| NGL Fine-Chem | 9.43B |
| Anlon Healthcare | 6.75B |